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Background: To compare effectiveness of everolimus-eluting stent (EES) and sirolimus-eluting stent (SES) in patients with diabetes mellitus (DM). 
There have been few intravascular ultrasound (IVUS) data showing a difference in efficacies of EES vs. SES in patients with DM.
methods: As a substudy of the ESSENCE-DIABETES (Randomized Comparison of Everolimus-Eluting Stent versus Sirolimus-Eluting Stent 
Implantation for De Novo Coronary Artery DisEase in Patients with DIABETES Mellitus) trial, we performed a volumetric IVUS substudy to compare 
intimal hyperplasia (IH), late stent malapposition, and vascular remodeling between 52 EES- and 38 SES-treated lesions.
results: The 2 groups had similar baseline clinical, angiographic, IVUS characteristics. The changes in minimal lumen area (MLA) (-0.5±1.1mm2 
vs. -0.4±0.8 mm2, p=0.664) and normalized lumen volume (-0.43±0.82 mm2 vs. -0.31±0.64 mm2, p=0.731) were not significantly different 
between EES and SES at 8 months. There was no significant difference in %IH volumes (7.8±5.6% vs. 7.1±6.2%, p=0.560) and normalized IH volume 
(0.6±0.5 mm2 vs. 0.5±0.4 mm2, p=0.453) at 8 months. Incidence of immediate post-stenting acute incomplete apposition was statistically not 
different between EES and SES (6% and 11%, p=0.328). However, late stent malapposition at follow-up was lower in EES vs. SES (8% vs. 24%, 
p=0.033). The %change in normalized vessel volume between post-stunting and 8-month follow-up was similar between EES and SES groups 
(1.2±5.9% vs. 2.7±7.7%, p=0.317).
conclusions: Both EES and SES implantation in diabetic patients showed similar performance in a serial volumetric IVUS analysis. However, EES 
implantation has a lower incidence of late stent malapposition, compared to SES implantation.
